The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal artificial intelligence models from baseline histopathology to predict prognosis in HR+ HER2- early breast cancer: Subgroup analysis.
 
Daniel Kates-Harbeck
No Relationships to Disclose
 
Hans Heinrich Kreipe
Honoraria - AstraZeneca; Genomic Health; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Genomic Health; Roche
 
Oleg Gluz
Stock and Other Ownership Interests - West German Study goup
Consulting or Advisory Role - Amgen; Celgene; Gilead Sciences; Lilly; Molecular Health; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagan
Speakers' Bureau - AstraZeneca; Exact Sciences
 
Matthias Christgen
No Relationships to Disclose
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Hologic; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; PINK; Roche/Genentech; Seagen; SOMATEX; Sonoscape; Stryker
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Roche
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Monika Karla Graeser
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Doris Mayr
No Relationships to Disclose
 
Rachel Wuerstlein
No Relationships to Disclose
 
Akinori Mitani
Employment - Artera Inc., Los Altos Co
Stock and Other Ownership Interests - Artera Inc., Los Altos Co
 
Jingbin Zhang
Employment - Artera
 
Hans Pinckaers
Employment - Artera Inc., Los Altos Co
Stock and Other Ownership Interests - Artera Inc., Los Altos Co
 
Yi Ren
Employment - Artera, INC.
Stock and Other Ownership Interests - Artera, INC.
 
Jessica Keim-Malpass
No Relationships to Disclose
 
Jacqueline Griffin
Employment - ArteraAI,
Stock and Other Ownership Interests - ArteraAI
Travel, Accommodations, Expenses - ArteraAI
 
Gijs Smit
Employment - ArteraAI
Stock and Other Ownership Interests - ArteraAI
 
Felix Y Feng
Stock and Other Ownership Interests - ArteraAI; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; Bluestar Genomics; Bristol-Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; Serimmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Andre Esteva
Employment - Artera
Leadership - Artera
Stock and Other Ownership Interests - Artera
Patents, Royalties, Other Intellectual Property - Artera's founding IP - multi-modal AI technology for cancer therapy personalization, using digital pathology.
Travel, Accommodations, Expenses - Artera
 
Ronald E. Kates
No Relationships to Disclose
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - AstraZeneca; Daiichi-Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; Viatris; Zuelligpharma
Consulting or Advisory Role - Gilead Sciences; Roche/Genentech; Seagen; West German Study Group (I)
Speakers' Bureau - EPG Communication; Medscape; Springer Healthcare
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)